Leukemia Cell Mobilization with Plerixafor Plus G-CSF with Busulfan/Fludarabine and Allogeneic Hematopoietic Cell Transplantation in Patients with AML/MDS Is Associated with Decreased Complete Chimerism and GvHD, and Increased Risk of Relapse

被引：1
|
作者：
Benton, Christopher B. [1 ]
Konopleva, Marina
Saliba, Rima M.
Shpall, Elizabeth J.
Ciurea, Stefan O. [2 ]
Kebriaei, Partow [2 ]
Alousi, Amin M. [2 ]
Popat, Uday R. [2 ]
Anderlini, Paolo [2 ]
Nieto, Yago [2 ]
Parmar, Simrit
Zeng, Zhihong [3 ]
Chen, Julianne J.
Rondon, Gabriela [2 ]
McMullin, Becky
Wang, Rui-Yu
Lu, Hongbo [3 ]
Schober, Wendy D. [3 ]
Woodworth, Glenda G.
Gulbis, Alison [4 ]
Cool, Rita [4 ]
Qiao, Wei [5 ]
Thall, Peter F.
Andreeff, Michael
Champlin, Richard E.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Sect Mol Hematol & Therapy, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.360.360
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
360
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Early achievement of full donor chimerism after allogeneic hematopoietic stem cell transplantation predicts lower relapse risk in patients with acute lymphoblastic leukemia
    Chen, Chien-Ting
    Gau, Jyh-Pyng
    Liu, Jing-Hwang
    Chiou, Tzeon-Jye
    Hsiao, Liang-Tsai
    Liu, Yao-Chung
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2018, 81 (12) : 1038 - 1043
  • [32] CFU-GM CAPACITY, ENGRAFTMENT, AND LONG-TERM GRAFT FUNCTION: A COMPARISON OF THREE METHODS OF PERIPHERAL BLOOD HEMATOPOIETIC STEM CELL MOBILIZATION (G-CSF, G-CSF plus PLERIXAFOR, OR CYCLOPHOSPHAMIDE plus G/GM-CSF) IN PATIENTS RECEIVING SIMILAR CD34+ CELL DOSES
    Alexander, E. T.
    Towery, J. A.
    Squires, J. E.
    Kramer, C.
    Stuart, R. K.
    Costa, L. J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S218 - S218
  • [33] Complete Remission with Incomplete Count Recovery (CRi) Prior to Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia Is Associated with a High Non-Relapse Mortality without Increased Relapse Risk
    Innes, Andrew James
    Woolley, Philippa
    Szydlo, Richard
    Lozano, Sara
    Fernando, Fiona
    Bansal, Divya
    Palanicawandar, Renuka
    Nadal-Melsio, Elisabet
    Yebra-Fernandez, Eva
    Apperley, Jane
    Olavarria, Eduardo
    Pavlu, Jiri
    BLOOD, 2018, 132
  • [34] A phase III, multicenter, randomized, double-blind, placebo-controlled, comparative trial of AMD3100 (Plerixafor) plus G-CSF vs. G-CSF plus Placebo for mobilization in multiple myeloma (MM) patients for autologous hematopoietic stem cell (aHSC) transplantation
    DiPersio, John
    Stadtmauer, Edward A.
    Nademanee, Auaypom P.
    Stiff, Patrick
    Micallef, Ivana
    Angell, J.
    Bridger, G.
    Calandra, Gary
    BLOOD, 2007, 110 (11) : 137A - 138A
  • [35] Missing HLA C group 1 ligand in patients with AML and MDS is associated with reduced risk of relapse and better survival after allogeneic stem cell transplantation with fludarabine and treosulfan reduced toxicity conditioning
    Shimoni, Avichai
    Vago, Luca
    Bernardi, Massimo
    Yerushalmi, Ronit
    Peccatori, Jacopo
    Greco, Raffaella
    Shem-Tov, Noga
    Lo Russo, Alessandro
    Danylesko, Ivetta
    Apel, Arie
    Bonini, Chiara
    Stanghellini, Maria Teresa Lupo
    Nagler, Arnon
    Ciceri, Fabio
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (10) : 1011 - 1019
  • [36] MISSING HLA C GROUP 1 LIGAND IN PATIENTS WITH AML AND MDS IS ASSOCIATED WITH REDUCED RISK OF RELAPSE AND IMPROVED SURVIVAL AFTER ALLOGENEIC STEM CELL TRANSPLANTATION WITH FLUDARABINE AND TREOSULFAN REDUCED TOXICITY CONDITIONING
    Shimoni, A.
    Bernardi, M.
    Yerushalmi, R.
    Peccatori, J.
    Shem-Tov, N.
    Lo Russo, A.
    Volchek, Y.
    Vago, L.
    Bonini, C.
    Stanghellini, M. T. Lupo
    Nagler, A.
    Ciceri, F.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S25 - S26
  • [37] Mixed chimerism at three months after allogeneic hematopoietic stem cell transplantation is a significant predictor of disease relapse in high-risk acute myeloid leukemia patients in first complete remission
    Michallet, M.
    Sobh, M.
    LabussiSre, H.
    Balsat, M.
    Lejeune, C.
    Mollet, I.
    Thomas, X.
    Barraco, F.
    Dubois, V.
    Nicolini, F. -E.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S446 - S446
  • [38] Mixed Chimerism at Three Months after Allogeneic Hematopoietic Stem Cell Transplantation Is a Significant Predictor of Disease Relapse in High-Risk Acute Myeloid Leukemia Patients in First Complete Remission
    Michallet, Mauricette
    Sobh, Mohamad
    Labussiere-wallet, Helene
    Balsat, Marie
    Lejeune, Caroline
    Mollet, Isabelle
    Moskovtchenko, Philippe
    Thomas, Xavier
    Barraco, Fiorenza
    Mialou, Valerie
    Dubois, Valerie
    Nicolini, Franck. E.
    BLOOD, 2015, 126 (23)
  • [39] Adverse side-effects associated with G-CSF in patients with chronic myeloid leukemia undergoing allogeneic peripheral blood stem cell transplantation
    Khoury, H
    Adkins, D
    Brown, R
    Vij, R
    Westervelt, P
    Trinkaus, K
    Goodnough, LT
    DiPersio, JF
    BONE MARROW TRANSPLANTATION, 2000, 25 (11) : 1197 - 1201
  • [40] Adverse side-effects associated with G-CSF in patients with chronic myeloid leukemia undergoing allogeneic peripheral blood stem cell transplantation
    H Khoury
    D Adkins
    R Brown
    R Vij
    P Westervelt
    K Trinkaus
    LT Goodnough
    JF DiPersio
    Bone Marrow Transplantation, 2000, 25 : 1197 - 1201
12345